Medicines Discovery Catapult
The Medicines Discovery Catapult has decades of experience across large pharma, academia, leading technology providers, SMEs, charities and start-ups. We are on hand to assist you in creating a clear experimental plan for your project, and then conducting specialised experiments in our state-of-the-art labs to deliver data critical for decision making. We support researchers throughout stages D2-D3 and T1 of the translational research pathway.
About Medicines Discovery Catapult
The Medicines Discovery Catapult has decades of experience across large pharma, academia, leading technology providers, SMEs, charities and start-ups. We are on hand to assist you in creating a clear experimental plan for your project, and then conducting specialised experiments in our state-of-the-art labs to deliver data critical for decision making. We also have cutting-edge data and informatics tools for the gathering, integration, and analysis of vast swathes of global research data.
What we offer:
- a clear, efficient and achievable experimental plan for your project
- cutting-edge specialist cell and tissue assay technology and expertise
- advanced preclinical imaging capabilities
- translational science to deliver biomarker and diagnostic validation
- referrals to a wide network of services
- advice and support at every stage of your project
- guidance on, and access to, tissue samples
- data interrogation at scale and pace
- access to our extensive integrated public and proprietary databases
- industry-leading scientific and engineering expertise
- cutting-edge data science, machine learning and artificial intelligence
We currently don’t have many projects with Â鶹´«Ã½ and would like to do more.
Stage
Researchers should approach the Medicines Discovery Catapult as early as possible, when they are writing a grant proposal or have CIC finding.
We support researchers throughout stages D2-D3 and T1 of the translational research pathway.
Contact
For more information, please visit the website, alternatively contact us via email.